Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study
- DOI
- 10.1016/j.jaad.2024.11.064
- Published
- 2025-04
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2024.11.064,
title = {Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study},
author = {Yuji Yamaguchi and Elena Peeva and Roni Adiri and Pranab Ghosh and Lynne Napatalung and Iltefat Hamzavi and Amit G. Pandya and Ronald N. Shore and Khaled Ezzedine and Emma Guttman-Yassky},
year = {2025},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2024.11.064},
url = {https://doi.org/10.1016/j.jaad.2024.11.064}
}RIS
TY - JOUR TI - Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study AU - Yuji Yamaguchi AU - Elena Peeva AU - Roni Adiri AU - Pranab Ghosh AU - Lynne Napatalung AU - Iltefat Hamzavi AU - Amit G. Pandya AU - Ronald N. Shore AU - Khaled Ezzedine AU - Emma Guttman-Yassky PY - 2025 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2024.11.064 UR - https://doi.org/10.1016/j.jaad.2024.11.064 ER -
APA
Yamaguchi, Y., Peeva, E., Adiri, R., Ghosh, P., Napatalung, L., Hamzavi, I., Pandya, A. G., Shore, R. N., Ezzedine, K., & Guttman-Yassky, E. (2025). Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2024.11.064
Source records
- crossref · retrieved 2026-09-26T17:09:14.936Z